Home > Healthcare > Drug Device Combination > Therapeutic Systems > bone void fillers market
Get a free sample of Bone Void Fillers Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Bone Void Fillers Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Bone Void Fillers Market size was valued at around USD 3.4 billion in 2023 and is projected to observe around 6.8% CAGR from 2024 to 2032. Bone void fillers are medical devices used to fill voids or defects in bone tissue. These voids may result from trauma, surgical procedures, bone infections, degenerative diseases, or congenital conditions. The purpose of bone void fillers is to promote bone healing, regeneration, and structural support in areas where bone loss or defects have occurred.
The increasing number of orthopedic surgeries is a significant driving factor for the market. For instance, in 2023, according to the American Academy of Orthopaedic Surgeons, the number of total hip arthroplasty (THA) and total knee arthroplasty (TKA) procedures increased substantially. It is projected that there will be a 70% growth in the annual volume of primary total joint arthroplasties (TJAs) by 2050, reaching 2,257,326 orthopedic surgeries. These procedures require bone void fillers to promote bone restoration, support structural integrity, and improve patient outcomes.
Furthermore, increasing incidence of bone disorders and injuries, rising adoption of orthopedic devices (market size is estimated to account for USD 73 billion by the end of year 2032), rise in geriatric population, advancements in surgical techniques, surging bone replacement, and government initiatives and funding, are the advancing factors fostering the growth of the market.
Abyrx, Inc., Baxter International Inc., Bioventus Inc., BONESUPPORT HOLDING AB, Johnson & Johnson, Medline Industries, Inc., Medtronic plc, Stryker Corporation, Wright Medical Group N.V. and Zimmer Biomet Holdings, Inc.
North America bone void fillers industry size was USD 1.4 billion revenue in 2023, attributed to the aging population and increased prevalence of orthopedic conditions such as fractures, osteoporosis, and degenerative bone diseases.
The putty segment accounted for USD 1 billion in 2023, as they are available in preserved and preservative-free forms for catering to different patient needs and preferences.
The global bone void fillers industry was valued at USD 3.4 billion in 2023 and is estimated to reach over USD 6.2 billion by 2032, driven by increasing incidence of bone disorders and injuries and the rising adoption of orthopedic devices.